According to Genmab's latest financial reports the company's total assets are A$10.16 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | A$10.27 B | 33.96% |
2023-12-31 | A$7.67 B | 20.36% |
2022-12-31 | A$6.37 B | 23.24% |
2021-12-31 | A$5.17 B | 13.79% |
2020-12-31 | A$4.54 B | 40.15% |
2019-12-31 | A$3.24 B | 76.24% |
2018-12-31 | A$1.84 B | 34.96% |
2017-12-31 | A$1.36 B | 32.52% |
2016-12-31 | A$1.02 B | 31.06% |
2015-12-31 | A$0.78 B | 37.22% |
2014-12-31 | A$0.57 B | 59.18% |
2013-12-31 | A$0.35 B | 24.42% |
2012-12-31 | A$0.28 B | 8.67% |
2011-12-31 | A$0.26 B | -39.04% |
2010-12-31 | A$0.43 B | -8.48% |
2009-12-31 | A$0.47 B | -45.08% |
2008-12-31 | A$0.86 B | -2.11% |
2007-12-31 | A$0.88 B | 118.31% |
2006-12-31 | A$0.40 B | 36.88% |
2005-12-31 | A$0.29 B | -0.89% |
2004-12-31 | A$0.29 B | 11.43% |
2003-12-31 | A$0.26 B | -34.12% |
2002-12-31 | A$0.40 B |